Sigma Diagnostics and MHA Announce Supply Agreement
"We are pleased to continue with Sigma Diagnostics as an approved MHA contract vendor with the Laboratory Program. Sigma has been a consistent partner with MHA in the past and continues to bring quality, innovative products to their customers," said Lawrence S. Irene, CEO of MHA. " This enhanced contract offering will continue to provide value to our members."
"Sigma Diagnostics looks forward to working closely with MHA and their member facilities. We see this new agreement and the Sigma commitment to quality as important steps we can take to assist MHA members in meeting the health care challenges of the next five years. We are especially pleased that MHA saw the value of our systems approach to EIA diagnostics and entered into this Primary Source agreement with Sigma," said Leo Griffin, Vice President of Sales for Sigma Diagnostics. "This new contract is a true win for all involved and we look forward to working with MHA to build on this success."
Sigma-Aldrich is a $1 billion life science company that develops, manufactures and distributes the broadest range of high quality biochemicals, organic chemicals, chromatography products and diagnostic reagents available in the world. Its products are used in high tech research and development in the life sciences, at universities and in industry, for the diagnosis of disease, and as specialty chemicals for pharmaceutical and other manufacturing purposes in more than 160 countries. Sigma-Aldrich is committed to the success of its customers, employees and shareholders through life science, technology and service. For more information about Sigma-Aldrich, please visit its award-winning web site at www.sigma-aldrich.com
MHA is headquartered in Florham Park, NJ, and has two offices located in Louisville, KY and Richmond, VA. It is the dominant Group Purchasing Organization to the long-term care industry, covering approximately 70% of the estimated 2.0 million long-term care beds in the U.S. Through acquisitions and internal growth, MHA has expanded to become a leading provider to the acute and non-acute health care, and veterinary markets. MHA's reach is a significant factor in its success providing products and services to over 4,714 facilities, including 1,182 long-term care customers servicing an estimated 1.4 million beds and 732 acute care facilities with 135,902 beds.
Other news from the department business & finance
These products might interest you
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!